| NCT ID | NCT05054738 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Alcoholism |
| Study Type | INTERVENTIONAL |
| Enrollment | 195 participants |
| Start Date | 2022-09-06 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 195 participants in total. It began in 2022-09-06 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate how well three types of treatments work to improve the outcomes for people with substance use problems. Veterans admitted to the Charleston VA Psychiatric inpatient unit may be invited to participate. The three types of treatments that will be evaluated are: 1. Combined Recovery Program (CRP), a six-session treatment group delivered on the inpatient unit. 2. A Home Telehealth program, called Stable and Able (S\&A), provided just prior to discharge and provides additional support for up to 3 months 3. Treatment-as-usual (TAU), which is the treatment currently provided on the unit, consisting of various mental health topics and sessions designed to help with recovery. Participation begins on the inpatient unit, beginning with CRP and/or TAU, and may continue with S\&A post discharge. Participants will be followed up at 1 and 3- months post treatment.
Eligibility Criteria
Inclusion Criteria: * Meeting DSM-V criteria for current SUD diagnosis of alcohol and/or illicit drug use disorder * Use of substances in past 30 days prior to date of index inpatient admission * Able to comprehend English * Able to provide informed consent * Functioning at an intellectual level sufficient to allow accurate completion of all assessments * Willing to commit to 6 group inpatient therapy sessions, telehealth S\&A, as well as baseline, and 1-and 3-month follow-up assessments Exclusion Criteria: * Auditory or visual impairment that would interfere with study procedures * Inability to speak or understand English * Acutely psychotic patients
Contact & Investigator
Elizabeth J. Santa Ana, PhD MA BA
PRINCIPAL INVESTIGATOR
Ralph H. Johnson VA Medical Center, Charleston, SC
Frequently Asked Questions
Who can join the NCT05054738 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alcoholism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05054738 currently recruiting?
Yes, NCT05054738 is actively recruiting participants. Contact the research team at Elizabeth.SantaAna2@va.gov for enrollment information.
Where is the NCT05054738 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT05054738 clinical trial?
NCT05054738 is sponsored by VA Office of Research and Development. The principal investigator is Elizabeth J. Santa Ana, PhD MA BA at Ralph H. Johnson VA Medical Center, Charleston, SC. The trial plans to enroll 195 participants.